Rhelion Life Sciences Secures New Patent for PEX010, Strengthening Its Psychedelic Medicine Leadership
Rhelion Life Sciences secures new Canadian psilocybin patent for PEX010, boosting its leading role in psychedelic medicine research and supply.
2 minutes to read